Heart disease and stroke

Area of Science:

• Cardiology
• Neurology
• Vascular Medicine

Background:

• Heart disease is a significant cause of cerebral infarction, accounting for 20-25% of cases.
• Patients with cardioembolic stroke face a 14-fold increased risk of early mortality compared to recurrent stroke.
• Effective management requires a dual focus on cardiac mortality reduction and stroke prevention.

Purpose of the Study:

• To outline diagnostic and treatment strategies for patients with suspected cardioembolic stroke.
• To emphasize the importance of identifying cardiac sources of emboli in cerebral infarction.
• To guide clinical decision-making in managing cardioembolic stroke.

Main Methods:

• Diagnostic test selection guided by clinical suspicion of cardiac disease, patient age, and exclusion of other stroke etiologies.
• Therapeutic strategies focused on mitigating cardiac mortality and preventing stroke recurrence.
• Review of current treatment guidelines for cardioembolic stroke management.

Main Results:

• Cardioembolism represents a substantial proportion of ischemic stroke cases.
• The risk of early death is significantly elevated in patients with cardioembolic stroke.
• Warfarin is the primary anticoagulant therapy, with aspirin as a viable alternative.

Conclusions:

• Accurate diagnosis of cardioembolic stroke is critical for appropriate management.
• Timely and effective treatment can significantly improve outcomes and reduce mortality.
• Anticoagulant therapy, particularly warfarin, is the cornerstone of preventing recurrent events in cardioembolic stroke.